L. Smith, J. Mosley, J. Yates, and L. Caswell, “The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy”, J Pharm Pharm Sci, vol. 19, no. 1, pp. 137–146, Mar. 2016.